WO2004092725A1 - 試薬の拡散距離が短縮された分析用具およびその製造方法 - Google Patents
試薬の拡散距離が短縮された分析用具およびその製造方法 Download PDFInfo
- Publication number
- WO2004092725A1 WO2004092725A1 PCT/JP2004/005434 JP2004005434W WO2004092725A1 WO 2004092725 A1 WO2004092725 A1 WO 2004092725A1 JP 2004005434 W JP2004005434 W JP 2004005434W WO 2004092725 A1 WO2004092725 A1 WO 2004092725A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- reagent
- reaction space
- analysis tool
- region
- sample
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/12—Specific details about manufacturing devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/16—Reagents, handling or storing thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0825—Test strips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0832—Geometry, shape and general structure cylindrical, tube shaped
- B01L2300/0838—Capillaries
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0887—Laminated structure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
Definitions
- the present invention relates to an analytical tool used for analyzing a specific component in a sample and a method for producing the same.
- FIG. 9 An example of an analytical tool used for measuring blood glucose level by colorimetry is a glucose sensor 9 shown in FIG.
- This glucose sensor 9 has a form in which first and second plate members 91 and 92 are joined via a pair of spacers 93.
- the Darcos sensor 9 has a cavity 94 defined by the elements 91 to 93 described above. Inside the cavity 94, a reagent section 95 is provided.
- the reagent section 95 is lysed when blood is supplied, and is configured to include a reaction component such as a coloring agent, an oxidoreductase, and an electron transfer substance.
- the reaction components and glucose contained in the reagent part 95 are diffused to cause a reaction, and electrons extracted from glucose are supplied to the color former via, for example, an electron transfer substance.
- the color former develops a color when supplied with electrons, and the color develops the color reaction system.
- the degree of coloring is detected by an optical method, and the blood sugar level can be calculated based on the detection result.
- the color former in order to cause the color former to develop a color, at least a reaction of extracting electrons from glucose and a reaction of supplying the extracted electrons to the color former are necessary.
- the reagent part 95 is configured to be dissolved by supplying the sample, after the local concentration (the part where the reagent part 95 was provided) of the reaction component is high, the reaction component is not dissolved. By diffusion over time, the concentration of the reaction components gradually becomes uniform.
- the measurement time tends to depend on the diffusivity of the reaction component.
- glucose is consumed in the liquid phase reaction system at a substantially uniform concentration.
- the glucose is consumed as the reaction progresses, and the unreacted glucose concentration is determined by the concentration of the reaction component. Is lower at higher points. Therefore, not only the reaction components but also the glucose concentration distribution, and hence the glucose diffusivity, will affect the measurement time.
- the reagent section 95 is formed only on the second transparent plate 92, and the distance H between the first transparent plate 91 and the second transparent plate 92 is usually set to 200 jwm or more. Therefore, in order to make the concentrations of the reaction components contained in the reagent part 95 uniform in the liquid phase reaction system, the diffusion distance of the target component is relatively large. Of course, the diffusion distance of glucose also increases. As a result, the glucose sensor 9 has a problem that the time required to obtain the desired reaction state (coloration of the liquid phase reaction system) is relatively long, and the measurement time is long.
- the measurement time is set to a short time, when measuring the concentration of blood with a high glucose concentration, it is not possible to obtain sufficient color for accurate concentration measurement, and the measurement accuracy in the high concentration region is reduced. I do. On the other hand, if you try to ensure sufficient measurement accuracy while keeping the measurement time short, the measurement range will be narrow.
- an unstable reagent such as methoxy-PMS
- methoxy-PMS a highly reactive reagent
- methoxy-PMS a highly reactive reagent
- storage stability is poor depending on the combination of the reagents, and measurement accuracy is deteriorated. Disclosure of the invention
- An object of the present invention is to provide an analysis tool that can shorten the analysis time, can analyze accurately even in a high concentration region, and has excellent storage stability.
- the analysis tool provided by the first aspect of the present invention includes a reaction space for reacting a specific component contained in a sample with a reagent, a reaction space disposed in the reaction space, and a sample supplied to the reaction space.
- An analytical tool comprising: a reagent portion that sometimes dissolves; and the reagent portion has first and second portions that face each other on a defining surface that defines the reaction space.
- the first and second parts are preferably formed as being separated from each other. However, the first and second parts may be formed as a continuous part.
- the composition of the first part and the composition of the second part have different compositions. Then, reagents that react easily during storage or the like can be distributed to the first and second parts so that they do not mix. Thereby, the reaction between the reagents during storage can be suppressed, and the storage stability can be improved. However, reagents having low reactivity during storage may be mixed in the same part of the first and second parts.
- the analysis tool of the present invention is configured so that a sample can be analyzed by colorimetry by, for example, including a coloring reagent in the reagent section.
- a coloring reagent in the reagent section can be applied to an analysis tool configured to be able to analyze a sample by the electrode method.
- the reagent section does not need to be configured to include a coloring reagent.
- the defining surface includes, for example, a first region provided with the first portion, and a second region provided with the second portion and facing the first region in a direction normal to the first region.
- the facing distance between the first region and the second region is preferably set to 300 m or less.
- the facing distance is preferably 200 ⁇ m or less, and more preferably 150 im or less.
- the facing distance is, for example, 30 ⁇ m or more. This is because when the facing distance is unduly small, when the sample contains solid components, such as blood containing blood cells, or when the viscosity of the sample is large, the sample moves in the flow path. This cannot be done smoothly.
- the analysis tool of the present invention is configured to include, for example, a first plate having a first region, and a second plate having a second region and defining a reaction space together with the first plate.
- the analysis tool of the present invention joins a first plate material and a second plate material, and It can also be configured to include a spacer that defines a reaction space. In this case, the facing distance can be specified by a spacer.
- the reaction space is configured to move the sample by, for example, a capillary force generated in the reaction space.
- the sample may be moved by using the power of a pump, and the analysis tool of the present invention does not necessarily need to be configured to be moved in the reaction space.
- a first reagent part forming step of forming one or more first reagent parts on a first substrate, and a second reagent part forming one or more second reagent parts on a second substrate Producing an analytical tool, comprising: a forming step; and an intermediate forming step of joining the first and second substrates to each other to form an intermediate such that the first and second reagent portions face each other.
- a method is provided.
- first substrate and second substrate include, in addition to those corresponding to the first and second plate materials in the analysis tool according to the first aspect of the present invention, a plurality of base materials to be these plate materials. Are also included.
- the production method of the present invention further include a cleavage part 11 for cutting the intermediate so that at least one of the first and second reagent parts is included.
- the first and second reagent parts are formed, for example, with different compositions. By doing so, it becomes possible to provide an analytical tool in which a highly reactive reagent and a reagent which reacts with this reagent are separated.
- the first and second reagent parts may be formed with the same or substantially the same composition.
- a spacer is provided on the surface of the first or second substrate on which the first or second reagent portion is formed, which is performed before the intermediate forming step and at least one of the first and second substrates.
- the method further includes a step of holding. This step is preferably performed before forming the first and second reagent portions on the first and second substrates. By doing so, it is possible to define the area where the reagent section is formed by the spacer, and it is possible to prevent the spacer from being held at the portion where the reagent section is formed. Can be suppressed.
- the above step may be performed after forming the first and second reagent parts.
- the spacer for example, a double-sided tape having adhesive properties on both sides is used. This eliminates the need to apply an adhesive to the spacer first or second substrate, thereby improving the efficiency of manufacturing the analytical tool.
- a colorimetric analysis tool provided with a reaction space for reacting a specific component contained in a sample with a reagent, and used for analyzing the specific component by colorimetry.
- the defining surface that defines the reaction space is a reagent holding region for holding a reagent and the reagent holding region in a direction normal to the reagent holding region facing the reagent holding region, and the reagent is not held.
- An analysis tool is provided in which a facing area is set, and a facing distance between the reagent holding area and the facing area is set to 150 ⁇ m or less.
- the facing distance is 100 im or less, and more preferably 75 m or less.
- the facing distance is, for example, 30 jw m or more. This is because the movement of the sample in the flow path is difficult when the sample distance is unduly small, the sample contains solid components, such as blood containing blood cells, or when the sample has a high viscosity. This is because they cannot be performed smoothly.
- the reaction space is configured so that the sample can be moved, for example.
- the sample can be moved by generating a capillary force in this reaction space and utilizing the capillary force.
- a pump it is also possible to use a pump to move the sample in the reaction space.
- the analysis tool of the present invention is configured to include, for example, a first plate member having a reagent holding region, and a second plate member having a facing region and defining a reaction space together with the first plate member.
- the analysis tool of the present invention can also be configured as a device that joins a first plate material and a second plate material and includes a spacer that defines a reaction space together with these plate materials. In this case, the facing distance can be specified by a spacer.
- the present invention can be applied to, for example, an analytical device using blood as a sample. Of course, the present invention can also be applied to an analysis tool that uses a sample other than blood, for example, urine.
- face-to-face is used to include not only the state between planes, but also the state between planes and curved surfaces and the state between curved surfaces, unless otherwise specified.
- the “face-to-face distance” means the maximum value of the distance required to reach the face-to-face area when the reagent diffuses from the reagent holding area in the normal direction.
- FIG. 1 is an overall perspective view showing a glucose sensor according to a first embodiment of the present invention.
- FIG. 2 is a cross-sectional view taken along the line II-III of FIG.
- FIG. 3 is a sectional view taken along the line m-in in FIG.
- FIG. 4A and FIG. 4B are cross-sectional views corresponding to FIG. 3 for explaining the progress of blood in the capillaries.
- FIG. 5 is an overall perspective view of a substrate used in the method for manufacturing the glucose sensor shown in FIGS.
- FIG. 6 is an overall perspective view showing a state where a double-sided tape is adhered to the substrate shown in FIG.
- FIG. 7 is an overall perspective view showing a primary intermediate in which a plurality of reagent parts are formed on the substrate in the state shown in FIG.
- FIG. 8 is an overall perspective view showing a step of joining two primary intermediates together.
- 9A to 9D are cross-sectional views showing another example of the glucose sensor according to the present invention.
- FIG. 10A is a partially cutaway perspective view showing still another example of the glucose sensor according to the present invention
- FIG. 10B is a sectional view thereof.
- FIG. 11 is an overall perspective view showing a glucose sensor according to the second embodiment of the present invention.
- FIG. 12 is a cross-sectional view taken along the line ⁇ - ⁇ in FIG.
- FIG. 13 is a cross-sectional view taken along the line x m— ⁇ ⁇ in FIG.
- FIG. 14A and 14B are diagrams for explaining the progress of blood in the capillaries.
- FIG. 14 is a sectional view corresponding to FIG.
- FIG. 15A is a partially cutaway perspective view showing another example of the glucose sensor according to the present invention
- FIG. 15B is a sectional view thereof.
- FIG. 16A is a partially cutaway perspective view showing still another example of the glucose sensor according to the present invention
- FIG. 16B is a sectional view thereof.
- FIG. 17A is a partially cutaway perspective view showing still another example of the glucose sensor according to the present invention
- FIG. 17B is a sectional view thereof.
- FIG. 18A to 18C are graphs showing the measurement results of the change over time in absorbance in Example 1.
- FIG. 18A to 18C are graphs showing the measurement results of the change over time in absorbance in Example 1.
- 19A to 19C are graphs showing the measurement results of the change over time in absorbance in Example 2.
- FIG. 20 is an overall perspective view for explaining a conventional glucose sensor. BEST MODE FOR CARRYING OUT THE INVENTION
- the glucose sensor X1 shown in FIGS. 1 to 3 is configured to be disposable and configured to measure the ligose concentration by colorimetry.
- the glucose sensor X1 has a form in which first and second rectangular plates 1 and 2 are joined via a pair of spacers 3.
- the glucose sensor X1 has a cabinet 4 defined by the elements 1 to 3.
- the first and second plates 1 and 2 are made of, for example, PET, PMMA, or vinylon, and are transparent. These plate members 1 and 2 are provided with first and second reagent portions 51 and 52 in a state of being accommodated in the interior of the cavity 4.
- Each of the reagent parts 51 and 52 is formed in a solid state that is easily dissolved in blood, and at least one of the reagent parts 51 and 52 is configured to contain a color former. Therefore, when blood is introduced into the capillary 4, a liquid-phase reaction system containing glucose and a coloring agent is established inside the capillary 4.
- the color former various known ones can be used. However, it is preferable to use one in which the absorption wavelength when coloring by electron transfer is shifted from the absorption wavelength of blood.
- Tataba Jincho (3- (4,5-0 ⁇ 61: 1 ⁇ to 2-1: 1 ⁇ 320 1) -2,5-( ⁇ 6 ⁇ 2H-tetrazolium bromi de) can be used.
- the first and second reagent sections 51 and 52 may be configured to include an electron transfer substance or an oxidoreductase. Then, the electron transfer between glucose and the color former can be performed more quickly, so that the measurement time can be shortened.
- oxidoreductase for example, glucose dehydrogenase (GDH) or dalcosoxidase (GOD) can be used, and PQQGDH is typically used.
- GDH glucose dehydrogenase
- GOD dalcosoxidase
- PQQGDH is typically used.
- [Ru (NH 3 ) 6 ] CI 3 , K 3 [Fe (CN) 6 ] or methoxy-PMS (5-methy I phenaz ini um methy I su Ifate) can be used as the electron mediator.
- compositions of the first and second reagent parts 51 and 52 may be the same or different. However, when using unstable reagents (reactive reagents) such as methoxy-PMS, it is preferable to separate such reagents from other reagents.
- the second reagent section 52 contains other reagents.
- the pair of spacers 3 define the distance between the first and second Itamura 1 and 2, that is, the height dimension H of the cab 4 and the width dimension W of the cab 4. belongs to.
- a pair of spacers 3 are arranged at a fixed interval, and the interval becomes the width dimension W of the cabillary 4.
- the thickness of each spacer 3 corresponds to the height H of the cavity 4.
- the inside of the cavity 4 communicates with the outside through openings 40 and 41.
- the opening 40 is for introducing blood into the capillary 4
- the opening 41 is for discharging air inside the capillary 4.
- blood moves inside the capillary 4 due to the capillary force generated inside the capillary 4.
- the width dimension W of the capillary 4 is set to, for example, 0.05 to 10 countries, and the height dimension (face-to-face distance) H of the capillary 4 is set to, for example, 301 to 1 country or less.
- the height H of the capillaries 4 is set to 300 m, and more preferably 200 m or less.
- the glucose sensor X1 when blood is supplied to the capillary 4 through the opening 40, as shown in FIG. 4A and FIG. 4B, the blood is supplied by the capillary force generated in the capillary 4. Proceed inside 4 In the course of the blood, the reagents 51 and 52 are dissolved by the blood, and a liquid phase reaction system 42 is constructed inside the capillary 4. The progress of the blood stops when the blood reaches the opening 41.
- the color-forming agent is supplied to the electron-powered coloring agent extracted from the glucose to develop a color, and the liquid-phase reaction system 42 is colored.
- the first or second reagent section 51, 52 contains an oxidoreductase and an electron mediator, the oxidoreductase specifically reacts with glucose in blood to extract electrons from glucose. After the electrons are supplied to the electron transfer material, they are supplied to the color former. Therefore, the degree of coloring of the coloring agent (the degree of coloring of the liquid-phase reaction system) is correlated with the amount of electrons extracted from the dalkose, that is, the glucose concentration.
- the degree of coloring of the liquid-phase reaction system 42 is determined, for example, by irradiating the liquid-phase reaction system 42 with light through the first plate 1 and then transmitting through the liquid-phase reaction system 42 to the second plate 2. It is detected by receiving the emitted light.
- As the light irradiated to the liquid phase reaction system 42 light having a wavelength with a large absorption in the developed color of the color former is employed.
- the final glucose concentration can be calculated based on the intensity of the light incident on the liquid phase reaction system 42 and the intensity of the transmitted light transmitted through the liquid phase reaction system 42.
- the first and second reagent portions 51, 52 are formed separately on the first and second plate members 1, 2 so as to face each other. Therefore, in the height direction of the cabillary 4, the diffusion distance of the coloring agent required to make the concentration of the coloring agent uniform is reduced.
- the coloring agent when the reagent portion is formed only on one of the first and second plate materials 1 and 2, if the coloring agent is not diffused to the surface of the plate material on which the reagent portion is not formed, the color is formed.
- the concentration of the agent cannot be made uniform.
- the reagent portions 51 and 52 are formed on the first and second plate materials 1 and 2, when the reagent portions 51 and 52 begin to dissolve, the coloring agent on the surface of each plate material is used. Concentration is high and the intermediate concentration is low Therefore, in order to make the concentration of the coloring agent uniform, the coloring agent may be diffused between the first and second plate members 1 and 2.
- the diffusion distance of the coloring agent necessary for equalizing the concentration of the coloring agent is one of the two. It is half of the case where the reagent part is formed only on the plate material.
- the concentration is increased for the same reason as the coloring agent.
- the diffusion distance of unreacted glucose required to homogenize is shorter. From this point as well, it can be said that the reaction time can be shortened by forming the first and second reagent portions 51 and 52 on the first and second plate materials 1 and 2.
- the measurement time can be further reduced by setting the facing distance ⁇ to 300 ⁇ m or less.
- the facing distance H the diffusion distance required to equalize the concentration of the coloring agent and unreacted glucose decreases in the height direction.
- the reaction required for coloring the color former is likely to occur, and the time required to obtain the desired reaction state (coloration of the liquid phase reaction system) is reduced. The time can be shortened.
- a method of manufacturing the glucose sensor X1 will be described with reference to FIGS.
- a transparent substrate 6 is prepared.
- the transparent substrate 6 has two A plurality of first and second cutting lines 61 and 62 extending in the direction are set, and a region surrounded by the cutting lines 61 and 62 is a glucose sensor forming region 63.
- a plurality of double-sided tapes 64 are attached at regular intervals so as to cover each first cutting line 61.
- a reagent portion 65 is formed in each glucose sensor forming region 63, and a first intermediate 66 is formed.
- Each reagent section 65 is formed by, for example, applying a reagent solution containing a color former, an oxidoreductase, and an electron transfer substance, and then drying and blowing the reagent solution.
- Another primary intermediate 66 is created, and as shown in FIG.
- the next intermediates 66 are joined together.
- the reagent portions 65 of the primary intermediates 66 are made to face each other, and the primary intermediates 66 are joined together by utilizing the adhesive force of the double-sided tape 64 to form the secondary intermediates. (Not shown) is created.
- the glucose sensor X1 shown in FIGS. 1 to 3 is obtained.
- the glucose sensor according to the present invention is not limited to the mode described in the present embodiment, and may have a configuration as shown in FIGS. 9A to 9D, 10A and 10B, for example.
- a first reagent portion 51A is formed on the first plate 1A, while a recess 20A having a rectangular cross section is formed on the second plate 2A.
- a second reagent portion 52A is formed inside the inside.
- the facing distance H is the distance between the bottom surface of the recess 20A and the first plate 1A.
- the glucose sensor X3 shown in FIG. 9B is one in which the cross section of the capillary 4B has a semicircular shape. More specifically, the glucose sensor X3 has a recess 20B having a semicircular cross section formed in the second plate 2B, and a second reagent portion 52B formed inside the recess 20B. . In the glucose sensor X3, the facing distance H is the distance between the deepest part of the recess 20B and the first plate 1B.
- the cross section of the capillary 4C is circular. More specifically, the glucose sensor X4 forms semicircular concave portions 10C and 20C in both the first and second plate members 1C and 2C, and the concave portions 10C and 20C.
- the first and second reagent portions 51C and 52C are formed on C.
- the glucose sensor X4 has a configuration in which the first and second reagent portions 51C and 52C are formed to be continuous with each other in the drawing, but the reagent portions 51C and 52C are separated from each other. You can also.
- the facing distance H is the diameter in the thickness direction of each of the plate materials 1C and 2C in the cabillary 4C.
- the cross-sectional shape of the capillary 4D is an oval. More specifically, the glucose sensor X5 forms a semicircular concave portion 10D.20D in both the first and second plate members 1D and 2D joined to each other via the spacer 3D.
- the first and second reagent portions 51D and 52D are formed in the concave portions 10D and 20D.
- the first and second reagent sections 51D, 52D are separated from each other by a spacer 3D.
- the facing distance H is the distance between the deepest positions of the concave portions 10D and 20D.
- the glucose sensor X6 shown in FIGS. 10A and 10B has a reagent section 70E formed inside a transparent circular tube 7E.
- the glucose sensor X6 has a circular capillary 71E similarly to the glucose sensor X6 shown in FIG.9C, except that the capillary 71E is defined by the circular tube 7E. This is different from the glucose sensor X4 shown in FIG. 9C.
- the facing distance H is the inner diameter of the circular tube 7E.
- the glucose sensor X7 shown in FIGS. 11 to 14 is configured as a disposable device that measures glucose concentration by colorimetry, and its basic configuration is the glucose sensor X1 (see FIGS. It is the same as Fig. 3). That is, the glucose sensor X7 has a form in which the first and second plate members 1 and 2 are joined via a pair of spacers 3F. A cabillary 4F extending in the longitudinal direction of the first and second plate members 1 and 2 is specified.
- the height dimension H 'of the capillary 4F and the arrangement of the reagent part 51F are different from those of the glucose sensor X1 (FIGS. 1 to 3) described above. It has been.
- the height dimension (face-to-face distance) H 'of the capillaries is less than 150 m.
- the height H ′ of the cabillary 4F is preferably set to 100 m or less, and more preferably 75 / m or less.
- the height dimension of the capillary 4F must be set to ensure that the sample (blood) is introduced into the capillary 4F.
- the height dimension H 'of the cabillary 4F can be adjusted by the thickness dimension of the spacer 3F.
- the reagent section 51F is provided only on the first plate 1.
- the reagent portion 51F is formed in a solid state that is easily dissolved in blood, and is configured to include, for example, a coloring agent, an electron transfer substance, and an oxidoreductase.
- a coloring agent for example, a coloring agent, an electron transfer substance, and an oxidoreductase.
- an oxidoreductase as the color former, the electron mediator, and the oxidoreductase, those similar to those described in the first embodiment can be used.
- the glucose sensor X7 when blood is supplied to the capillary 4F through the opening 40, the blood is generated by the capillary force generated in the capillary 4F. Proceed inside F. At this time, the reagent part 51F is dissolved by the blood, and a liquid phase reaction system 42F is constructed inside the capillary 4. In the liquid-phase reaction system 42F, the coloring agent develops a color, and the degree of the color development (the degree of coloring of the liquid-phase reaction system) is the same as that of the glucose sensor X1 described above (see FIGS. 1 to 3). An apple is served.
- the measurement time can be shortened because the face-to-face distance H ′ is smaller than 150 m or less than usual.
- the concentration of the target components (coloring agent, oxidoreductase, electron transfer substance) contained in the reagent portion 51F is required to be uniform.
- the diffusion distance decreases in the height direction. Even when glucose is consumed by the reaction, the diffusion distance of glucose for uniformly dispersing unreacted glucose is smaller in the height direction than that of a normal glucose sensor.
- the reaction required for coloring the color former is likely to occur, and the time required to obtain the desired reaction state (coloration of the liquid phase reaction system) is reduced. Save time Can be done.
- the glucose sensor according to the present invention is not limited to the form described in the present embodiment, and may have a configuration as shown in FIGS. 15 to 17, for example.
- the glucose sensor X8 shown in FIGS. 15A and 15B has a recess 10G having a rectangular cross section formed in the first plate 1G, and a reagent portion 51G formed on the bottom surface of the recess 10G.
- this glucose sensor X8 as shown in FIG.
- the glucose sensor X9 shown in FIGS. 16A and 16B is one in which the cross-sectional shape of the capillary 4H is semicircular. More specifically, a concave portion 10H having a semicircular cross section is formed in the first substrate 1H, and a reagent portion 51H is formed on the inner surface of the concave portion 10H. In this glucose sensor X9, as shown in FIG.
- the glucose sensor X10 shown in FIGS. 17A and 17B is one in which the cross section of the capillary 4I is circular. More specifically, in the glucose sensor X10, semicircular concave portions 10I and 20I are formed in both the first and second plate members 1I and 2I, and the concave portions of the first plate member 1I are formed. The reagent part 51 I is formed on 10 I. In the glucose sensor 10, as shown in FIG. 17, the facing distance H ′ is the diameter of the capillary 4I.
- the glucose sensor configured to be able to measure the glucose concentration based on the intensity of the incident light and the transmitted light has been described.
- the present invention can be applied to a glucose sensor configured to measure a glucose concentration.
- the glucose sensor according to the first embodiment of the present invention is not limited to a glucose sensor configured to measure a glucose concentration by colorimetry, and is configured to measure a ligose concentration by an electrode method.
- the present invention can also be applied to a glucose sensor that has been used.
- Glucose sensors X1 to ⁇ ⁇ ⁇ ⁇ 10 in each of the embodiments are arranged such that a sample is sampled by capillary force.
- the structure may be such that the sample is moved by the power of a force pump or the like that is configured to move, and it is not always necessary to adopt a structure that moves the sample.
- the present invention can also be applied to the analysis of components other than glucose in blood, such as cholesterol, and to the analysis of samples other than blood, such as urine.
- components other than glucose in blood such as cholesterol
- samples other than blood such as urine.
- the effect of the height dimension (face-to-face distance) of the capillaries on the glucose sensor on the measurement time was examined by measuring the change over time in absorbance.
- glucose sensors (1) to (3) were used. These glucose sensors (1) to (3) have basically the same configuration. By regulating the thickness of the double-sided tape (spacer), the height of the capillaries as shown in Table 1 is determined. The dimensions (face-to-face distance) are different from each other.
- Each glucose sensor (1) to (3) was prepared as follows. First, a pair of double-sided tapes were adhered to a first transparent plate made of PET measuring 10 mm ⁇ 30 countries 30 ⁇ .2 mm with an interval of 3 countries. The double-sided tape defines the thickness dimension of the capillaries. The thickness of the double-sided tape used for each glucose sensor (1) to (3) is as shown in Table 1. Next, after dispensing a reagent solution having the composition shown in Table 1 in the area of 3 countries x 3 mm between a pair of double-sided tapes, the reagent solution is blown dry (30 ° C, 10% Rh) and Part was formed. The dispensed amount of the reagent solution when preparing each of the glucose sensors (1) to (3) is as shown in Table 1.
- the dispensed amount of the reagent solution is set according to the volume of the capillary, and the glucose sensors (1) to (3) have the same reagent concentration in the capillary when blood is introduced into the capillary. It is set to be.
- a glucose sensor (1) to (1) to (1) to (2) is used by joining a second transparent plate made of PET measuring 10 mm X 30 mm X 0.2 mm to the first transparent plate via a double-sided tape. 3) get Table 1: Configuration of glucose sensor used in Example 1
- PQQGDH darco bis dehydrogenase (GDH) using pyro-mouth quinoline quinone (PQQ) as a coenzyme
- PMS is 5-methy I phenazinium methy I su Ifate
- country T is 3-(4, 5-D i methy I -2-th iazolyl) -2, 5-di pheny I -2H-tetrazo I i um brom i de
- PI PES is P i peraz i ne-1, 4-bis (2-ethanesu 0 which is an abbreviation for Ifonic aci d)
- the absorbance of each of the glucose sensors (1) to (3) was measured over time for blood having a concentration of 0 mg / d and corresponding to 200 [200, 400 mg / dL, or 600 mg / dL.
- the area where the reagent section was provided was irradiated with light along the height direction of the capillary, and at that time, the light transmitted through the glucose sensor was received.
- Light irradiation was performed by irradiating light of 630 nm using a light emitting diode.
- the transmitted light was received by a photodiode.
- the absorbance was calculated by the following equation.
- ABS ABS (absorbance logd)
- FIGS. 18A to 18C show the measurement results of the change with time in the absorbance of each of the glucose sensors (1) to (3).
- the glucose sensor (1) with a double-sided tape (capillary) thickness of 200 Hi has a small change in absorbance with time and the glucose concentration is 400 mg / dL or 600 mg / dL. Is not sufficiently asymptotic to the maximum absorbance 30 seconds after the start of blood introduction. Therefore, in the glucose sensor (1), blood If it is difficult to measure the glucose concentration within 30 seconds from the start of introduction, and if the glucose concentration is accurately measured within 30 seconds from the start of blood introduction, the measurement range must be narrowed.
- a 100 ju iri glucose sensor (2) with a double-sided tape (capillary) thickness (face-to-face distance) even when the glucose concentration was 600 mg / dL, blood was introduced. About 10 seconds after the start, it is sufficiently asymptotic to the maximum absorbance. Therefore, in the glucose sensor (2), it is possible to accurately measure the glucose concentration within about 10 seconds from the start of blood introduction, at least when the glucose concentration is in the range of 0 to 600 mg / dL. .
- the Darcos sensor (3) for the thickness (face-to-face distance) of the double-sided tape (capillaries) shows that even when the glucose concentration is 600 mg / dL, it takes about 5 seconds from the start of blood introduction And is sufficiently asymptotic to the maximum absorbance. Therefore, in the Darcos sensor (3), it is possible to accurately measure the glucose concentration within about 5 seconds from the start of blood introduction, at least in the range of 0 to 600 mg / dL.
- the measurement time is shortened by reducing the distance in the normal direction (face-to-face distance) of the reagent part in the capillary, for example, to 150 m or less, more preferably 75 j ⁇ m or less. It can be said that it is possible.
- the glucose sensor (4) has a reagent section on both the first and second plates (see Figures 1 to 3) Is formed.
- a first reagent portion is formed between the pair of double-sided tapes, while a pair of double-sided tapes is adhered to the second plate.
- a second reagent portion was formed between the pair of double-sided tapes, and the first and second plate members were joined together such that the first and second reagent portions faced each other.
- portions different from those of the Darcos sensors (1) to (3) of Example 1 are shown in Table 2, but information not described in Table 2 is described in the glucose sensor (4). Same as 1) to (3).
- the glucose sensors (5) and (6) have a reagent portion formed only on the first plate member, and have the glucose sensors (1) to (1) of Example 1 so as to have the configuration shown in Table 2 below. It was created in the same way as 3).
- FIGS. 19A to 19C show the measurement results of the change with time in the absorbance of each of the glucose sensors (4) to (6).
- the change in absorbance with time was small, and when the glucose concentration was 600 mg / dL, the absorbance reached the maximum even after 30 seconds from the start of blood introduction. It is not asymptotic enough. Therefore, in the glucose sensor (5) in which the reagent section is provided only on one side, even if the height of the capillaries (face-to-face distance) and the composition of the reagent section are the same as those of the glucose sensor (4), 30 If it is difficult to measure glucose concentration within seconds, and if glucose concentration is accurately measured within 30 seconds from the start of blood introduction, the measurement range must be narrowed.
- the glucose sensor (6) has obtained the same result as the glucose sensor (4).
- the glucose sensor (4) provided with the two facing reagent parts substantially the same effect as in the case where the facing distance is small (the glucose sensors (2) and (3) in Example 1) can be obtained. ing.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04727733A EP1615031A4 (en) | 2003-04-16 | 2004-04-15 | REMOTE REAGENT DISTRIBUTED DIFFUSION DISTANCE ANALYSIS INSTRUMENT AND METHOD FOR MANUFACTURING THE SAME |
US10/553,336 US20070053790A1 (en) | 2003-04-16 | 2004-04-15 | Analyzing tool being reduced in distance of diffusion of reagent and method for manufacture thereof |
CN200480010320.XA CN1774628B (zh) | 2003-04-16 | 2004-04-15 | 缩短试药的扩散距离的分析用具及其制造方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-111948 | 2003-04-16 | ||
JP2003-111950 | 2003-04-16 | ||
JP2003111948A JP2004317307A (ja) | 2003-04-16 | 2003-04-16 | 試薬部対面分析用具およびこの分析用具の製造方法 |
JP2003111950A JP2004317308A (ja) | 2003-04-16 | 2003-04-16 | 小ギャップ比色分析用具 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004092725A1 true WO2004092725A1 (ja) | 2004-10-28 |
Family
ID=33302217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/005434 WO2004092725A1 (ja) | 2003-04-16 | 2004-04-15 | 試薬の拡散距離が短縮された分析用具およびその製造方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20070053790A1 (ja) |
EP (1) | EP1615031A4 (ja) |
WO (1) | WO2004092725A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005066638A1 (ja) * | 2004-01-07 | 2005-07-21 | Arkray, Inc. | 試薬部の配置を改良した分析用具および分析方法 |
DE202012012743U1 (de) | 2011-07-19 | 2013-10-10 | Harry Gaus | Dekanterzentrifuge |
EP4116405A1 (en) * | 2021-07-07 | 2023-01-11 | Koninklijke Philips N.V. | Fluidic device and method of manufacturing the same |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2017006A1 (en) | 2007-07-20 | 2009-01-21 | Koninklijke Philips Electronics N.V. | Microfluidic methods and systems for use in detecting analytes |
TWI460423B (zh) | 2007-10-31 | 2014-11-11 | Arkray Inc | Biosensor and its manufacturing method |
ES2568464T3 (es) * | 2010-07-23 | 2016-04-29 | F. Hoffmann-La Roche Ag | Composiciones que contienen tampón zwiteriónico y usos en dispositivos y métodos electroanalíticos |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03223674A (ja) * | 1989-11-30 | 1991-10-02 | Mochida Pharmaceut Co Ltd | 反応容器 |
JP2000116626A (ja) * | 1998-10-15 | 2000-04-25 | Kdk Corp | 体液測定装置および装着体 |
JP2002333420A (ja) * | 2001-03-07 | 2002-11-22 | Matsushita Electric Ind Co Ltd | バイオセンサおよび基質の定量方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU642444B2 (en) * | 1989-11-30 | 1993-10-21 | Mochida Pharmaceutical Co., Ltd. | Reaction vessel |
US5962215A (en) * | 1996-04-05 | 1999-10-05 | Mercury Diagnostics, Inc. | Methods for testing the concentration of an analyte in a body fluid |
DE69720391T2 (de) * | 1996-12-20 | 2004-02-12 | Matsushita Electric Industrial Co., Ltd., Kadoma | Cholesterinsensor und Verfahren zu seiner Herstellung |
JPH11304748A (ja) * | 1998-04-23 | 1999-11-05 | Omron Corp | バイオセンサ |
US6471839B1 (en) * | 1999-05-20 | 2002-10-29 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
WO2001061041A2 (en) * | 2000-02-18 | 2001-08-23 | Aclara Biosciences Inc. | Multiple-site reaction device and method |
AU2000280282A1 (en) * | 2000-10-17 | 2002-04-29 | Abbott Laboratories | Diagnostic assay for a sample of biological fluid |
US6821410B2 (en) * | 2001-03-07 | 2004-11-23 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method of substrate quantification |
-
2004
- 2004-04-15 WO PCT/JP2004/005434 patent/WO2004092725A1/ja active Application Filing
- 2004-04-15 US US10/553,336 patent/US20070053790A1/en not_active Abandoned
- 2004-04-15 EP EP04727733A patent/EP1615031A4/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03223674A (ja) * | 1989-11-30 | 1991-10-02 | Mochida Pharmaceut Co Ltd | 反応容器 |
JP2000116626A (ja) * | 1998-10-15 | 2000-04-25 | Kdk Corp | 体液測定装置および装着体 |
JP2002333420A (ja) * | 2001-03-07 | 2002-11-22 | Matsushita Electric Ind Co Ltd | バイオセンサおよび基質の定量方法 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1615031A4 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005066638A1 (ja) * | 2004-01-07 | 2005-07-21 | Arkray, Inc. | 試薬部の配置を改良した分析用具および分析方法 |
EP1712919A1 (en) * | 2004-01-07 | 2006-10-18 | Arkray, Inc. | Analytical instrument having improved arrangement of reagent section and analytical method |
EP1712919A4 (en) * | 2004-01-07 | 2009-08-12 | Arkray Inc | ANALYZER WITH IMPROVED ARRANGEMENT OF REAGENT AREA AND ANALYSIS PROCEDURE |
US7780828B2 (en) | 2004-01-07 | 2010-08-24 | Arkray, Inc. | Analytical instrument having improved arrangement of reagent section and analytical method |
DE202012012743U1 (de) | 2011-07-19 | 2013-10-10 | Harry Gaus | Dekanterzentrifuge |
EP4116405A1 (en) * | 2021-07-07 | 2023-01-11 | Koninklijke Philips N.V. | Fluidic device and method of manufacturing the same |
WO2023280808A1 (en) * | 2021-07-07 | 2023-01-12 | Koninklijke Philips N.V. | Fluidic device and method of manufacturing the same |
Also Published As
Publication number | Publication date |
---|---|
EP1615031A4 (en) | 2011-01-12 |
EP1615031A1 (en) | 2006-01-11 |
US20070053790A1 (en) | 2007-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4717637B2 (ja) | 試薬部の配置を改良した分析用具および分析方法 | |
EP1723412B1 (en) | Analyte test system for determining the concentration of an analyte in a physiological fluid | |
US20090169430A1 (en) | Panel for analyzing sample liquid | |
WO2007052648A1 (ja) | 試料分析用ディスク | |
WO2017134878A1 (ja) | 血糖値測定試薬、血糖値測定チップ、及び血糖値測定装置セット | |
JP2003534526A (ja) | 少量生物体液試料用診断アッセイ | |
JPWO2004113927A1 (ja) | 液溜部を備えた分析用具 | |
JP7208219B2 (ja) | 生体試料中の分析対象物濃度を測定するための、方法、試薬およびチップ | |
JP2022186748A (ja) | 血糖値測定チップ及び血糖値測定装置セット | |
BR112014007584A2 (pt) | medição de ácido lático em fluidos biológicos | |
WO2004092725A1 (ja) | 試薬の拡散距離が短縮された分析用具およびその製造方法 | |
CN103217521B (zh) | 干试剂的制造方法、干试剂、以及使用其的分析用具 | |
JPWO2018051822A1 (ja) | 2−置換ベンゾチアゾリル−3−置換フェニル−5−置換スルホ化フェニル−2h−テトラゾリウム塩、ならびに当該塩を含む生体成分濃度測定用試薬および当該塩を用いる生体成分濃度の測定方法 | |
JP2004317307A (ja) | 試薬部対面分析用具およびこの分析用具の製造方法 | |
WO2023112442A1 (ja) | 生体成分濃度測定試薬、測定方法およびセンサ | |
JP2023087327A (ja) | 生体成分濃度測定試薬、測定方法およびセンサ | |
JP2023087330A (ja) | 生体成分濃度測定試薬、測定方法およびセンサ | |
JP2004317308A (ja) | 小ギャップ比色分析用具 | |
JP3867081B2 (ja) | 酸化還元指示薬としてのアミン−n−オキサイドによるアナライトの蛍光測定 | |
JP7372310B2 (ja) | 血糖値算出プログラム、血糖値算出方法及び血糖値測定装置 | |
JP5812672B2 (ja) | 乳酸脱水素酵素測定用試験片 | |
JP2010008183A (ja) | クレアチニン測定方法、クレアチニン測定デバイス、及びクレアチニン測定装置、並びにそれらを用いた尿中塩分量測定方法、尿中塩分量測定デバイス、及び尿中塩分量測定装置 | |
JP2017142199A (ja) | 血糖値測定試薬、血糖値測定チップ、及び血糖値測定装置セット |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004810320X Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004727733 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004727733 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007053790 Country of ref document: US Ref document number: 10553336 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10553336 Country of ref document: US |